Book Now

Acute & Urgent Care 51 guides

Bites, infections, pain, respiratory, and other same-day concerns.

Skin Conditions 15 guides

Rashes, eczema, acne, and dermatology conditions treatable via telehealth.

Sexual Health & STIs 19 guides

STI testing, treatment, and prevention with evidence-based sourcing.

Chronic Conditions & Medication 8 guides

Long-term conditions, medication refills, and ongoing management.

Men's & Women's Health 13 guides

Hormonal, reproductive, and gender-specific care.

AI in Medicine 7 guides

How AI chatbots perform against physicians, hallucination rates, safety, and regulation.

Telehealth Evidence 6 guides

Clinical evidence for what telehealth actually does well, condition by condition.

Travel Medicine 12 guides

Prescriptions and care for international visitors, mobile workers, and travelers.

Lifestyle & Specialty 7 guides

Aesthetic dermatology, weight management, and quality-of-life care.

Pediatric Care 2 guides

Physician-reviewed guides for parents on common childhood conditions, age-banded red flags, and school return rules.

At-Home Testing 4 guides

Honest reviews of consumer home test kits and how to interpret results.

Paying for Care 10 guides

Deductibles, coinsurance, medical bills, and medical debt, explained in plain language.

Clinical updates

New evidence, explained

FDA actions, guideline changes, and new trials, with what they mean for patients.

AI in Medicine

AI Chatbot Mental Health Lawsuits: What Settlements Reveal About Crisis Response Failures

Series Week 4 of 6. The January 2026 Character.AI/Google settlements document systemic failure patterns: no escalation protocols, no age-gating, no parental notification. What the NAM panel found about adolescent susceptibility, and where supervised AI reliably helps in mental health.

Jun 29, 2026 · 9 min read
At-Home Testing

Everlywell STI Test Panel Review: What the Evidence Says About Mail-In Sexual Health Testing

Evidence assessment of Everlywell's mail-in STI panel, self-collected NAAT accuracy, dried blood spot serology performance, uptake data, what the panel covers, and dual-path next steps after a positive result.

Jun 24, 2026 · 9–11 min read
AI in Medicine

Hallucination Rates in Medical AI: What the Citation Fabrication Data Tells Us

Series Week 3 of 6. GPT-3.5 fabricates 55% of citations. Bard hallucinates 91.4% of medical references. A peer-reviewed breakdown of AI hallucination rates across models and tasks, and where verification is essential vs. where AI adds reliable value.

Jun 22, 2026 · 8–10 min read
Telehealth Evidence

Antibiotic Stewardship in Telehealth: What the 2026 Evidence Shows

The 2026 evidence on antibiotic prescribing quality in virtual care, sinusitis may see less prescribing than in-person, UTI stewardship outperforms respiratory, and CDC Core Elements cut hospitalizations when implemented.

Jun 17, 2026 · 8 min read
AI in Medicine

The Bixonimania Experiment: How a Fake Disease Fooled ChatGPT, Gemini, and Copilot

Series Week 2 of 6. Scientists invented a disease with fictional funding sources and obvious fabrication clues, then watched three major AI systems describe it as a real medical diagnosis. What the experiment reveals about AI reliability and the 12-fold rise in fabricated citations.

Jun 2026 · 9 min read
Clinical Update

FDA Approves Xocova (Ensitrelvir) for COVID-19 Post-Exposure Prophylaxis: What the Evidence Shows

FDA approved ensitrelvir on May 29, 2026 for COVID-19 post-exposure prophylaxis -- the first PEP option to clear US regulatory review. The trial evidence, the dosing window, and how it differs from Paxlovid.

Jun 2026 · 9 min read
AI in Medicine

FDA's First AI Warning Letter: What April 2026's Enforcement Action Means for Healthcare AI

Series Week 1 of 6. The FDA's April 2, 2026 Warning Letter to Purolea Cosmetics is the first cGMP enforcement explicitly citing AI misuse. FDA didn't ban AI -- it required human review and quality-unit oversight. The precedent for every AI-in-healthcare deployment.

Jun 2026 · 9 min read
Telehealth Evidence

Telehealth for Skin Condition Triage: When Photos Are Enough

A 44-study meta-analysis shows photo-based dermatology agreement reaches 76% with proper photo standards. The evidence on which skin conditions are safely managed by image alone -- and which still need in-person dermoscopy or biopsy.

Jun 2026 · 9 min read
Clinical Update

AUA 2026 BPH Guideline: What's Changed and What It Means for Patients

The American Urological Association just released a 62-recommendation overhaul of BPH/LUTS care: PAE upgraded to Grade B, Aquablation expanded to larger prostates, tadalafil + 5-ARI combo formalized, and HIFU/cryoablation restricted to trials.

May 2026 · 9 min read
Master Guide

What Conditions Can Be Treated Through Telehealth: The Complete 2026 Evidence-Based Guide

The full editorial map of telehealth in 2026. A three-tier decision framework, evidence by category, red flags that require in-person care, and links to all 49 condition guides plus the new At-Home Testing track.

May 2026 · 20 min read
Clinical Update

Long COVID in 2026: What We Now Know About Treatment

RECOVER-VITAL Paxlovid and ENERGIZE Metformin both failed as treatments in 2026 trials. Metformin still cuts Long COVID risk 41-63% when started during acute infection. Here's what the evidence supports now.

May 2026 · 9 min read
Clinical Update

FDA Moves to Close a Compounded GLP-1 Loophole: What the 503B Proposal Means for Patients

FDA's April 30 proposal would exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list. 100+ hospitalizations and 10+ deaths have been linked to compounded versions.

May 2026 · 8 min read

How these are written

The same reasoning used in the exam room.

These are not rewritten patient handouts. Each guide follows the evidence review and clinical judgment that go into real visits, written so a patient can follow it.

Questions

About the Health Guides

Who writes these guides?

Every guide is written and reviewed by Parth Bhavsar, MD, a board-certified family medicine physician and the founder of TeleDirectMD. They are not outsourced, ghostwritten, or generated from other websites. Each guide shows the month it was last clinically reviewed.

How do you keep them current?

Guides are checked against new recommendations from the CDC, USPSTF, IDSA, AAD, AUA, and ACOG, and revised when guidance changes. The review date on each guide reflects the most recent check. Errors are corrected under the corrections policy.

Is this medical advice?

No. The guides explain how a physician thinks about common conditions so you can make better decisions about care. They do not replace an evaluation by a clinician who knows your history.

Can I be treated for something I read about here?

Many of the conditions covered can be evaluated by video, and the guides say plainly when a condition needs an in-person exam, labs, or imaging instead. TeleDirectMD visits are $79 flat fee in 40+ states, with insurance accepted in select states. See what we treat.

Do companies pay to be mentioned?

No. There is no sponsored content and there are no affiliate links. Reviews of at-home tests are independent, and no manufacturer sees a review before it is published.

$79 Flat FeeInsurance accepted in select states
Book Now